Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1129459
Abstract: Although most individuals recover from acute SARS-CoV-2 infection, a significant number continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the unexplained symptoms that are frequently referred to as long COVID, which could last… read more here.
Keywords: recover initiative; long covid; covid call; therapeutic trials ... See more keywords